FLSC SEC Filings, Earnings & Splits

Bong Y. Koh filed a Power of Attorney authorizing representatives of Venrock to prepare and file Schedule 13D/13G and Section 16 filings on his behalf. This is an administrative filing related to his holdings in Frazier Life Sciences Acquisition Corp. II.

RA Capital Management, Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund filed a joint filing agreement as an exhibit to a Schedule 13G regarding their beneficial ownership of Frazier Life Sciences Acquisition Corp. II Class A ordinary shares.

Frazier Life Sciences Acquisition Corp. II completed its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75 million in gross proceeds, alongside a $3 million private placement of 300,000 shares to its sponsor. A total of $75 million was placed in a trust account for the benefit of public shareholders.

A Schedule 13G was filed regarding Frazier Life Sciences Acquisition Corp. II, indicating a passive ownership position by an institutional or other holder. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.

A group of Biotechnology Value Fund entities and Mark N. Lampert filed a joint filing agreement under Schedule 13G regarding their ownership of Class A ordinary shares of Frazier Life Sciences Acquisition Corp. II.

Frazier Life Sciences Acquisition Corp. II filed a Schedule 13D, indicating a holder has acquired a 5% or greater beneficial ownership stake in the company. The filing includes an exhibit (ck0000000000-ex99_1.pdf) but the specific holder, ownership percentage, and purpose are not disclosed in the available text.

Coastlands Capital LP and affiliated entities filed a joint filing agreement (Exhibit 99.1) under Schedule 13G regarding their purchases of securities of Frazier Life Sciences Acquisition Corp. II. The agreement appoints Coastlands Capital LP as attorney-in-fact for joint SEC filings.

Frazier Life Sciences Acquisition Corp. II completed its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75 million in gross proceeds, and simultaneously closed a $3 million private placement of 300,000 shares to its sponsor. The company also entered into several customary agreements including an underwriting agreement, trust agreement, registration rights agreement, forward purchase agreement, and letter agreement.